Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities.

Myo Min, Kay K; Ffrench, Charlie B; Jessup, Claire F; Shepherdson, Mia; Barreto, Savio George; Bonder, Claudine S

Myo Min, Kay K; Ffrench, Charlie B; Jessup, Claire F; Shepherdson, Mia; Barreto, Savio George; Bonder, Claudine S.

Afiliación

Myo Min KK; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia.
Ffrench CB; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, SA 5000, Australia.
Jessup CF; College of Medicine & Public Health, Flinders University, Bedford Park, SA 5042, Australia.
Shepherdson M; Adelaide Medical School, University of Adelaide, Adelaide, SA 5000, Australia.
Barreto SG; College of Medicine & Public Health, Flinders University, Bedford Park, SA 5042, Australia.
Bonder CS; Hepatopancreatobiliary & Liver Transplant Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, SA 5042, Australia.

Cancers (Basel) ; 15(8)2023 Apr 18.

Article en En | MEDLINE | ID: mdl-37190281

Palabras clave

desmoplasia; immunotherapy; pancreatic ductal adenocarcinoma; targeted therapy; tumour microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google